Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03892980 · ClinicalTrials.gov registry record · NA
Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy
A NA study of Nipple Sparing Mastectomy, sponsored by Intuitive Surgical.
- Active
- Registry status
- NA
- Development phase
- 145
- Enrollment target
- 6
- Study locations
NCT03892980: Active NA study of Nipple Sparing Mastectomy, sponsored by Intuitive Surgical.
NCT03892980 is a NA study of Nipple Sparing Mastectomy that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 145 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03892980, a NA study of Nipple Sparing Mastectomy, is active but no longer recruiting, sponsored by Intuitive Surgical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study evaluates the safety and effectiveness of the da Vinci Surgical Systems in prophylactic Nipple Sparing Mastectomy procedures.
Primary Outcome
Conversion is defined as conversion of da Vinci robotic-assisted surgery to open surgery
Conditions Studied
Interventions
- DEVICE Nipple-Sparing Mastectomy
Study Locations (6)
Florida
- Mayo Clinic Florida - Jacksonville
Illinois
- NorthShore University Health System - Evanston
Minnesota
- Mayo Clinic - Rochester
New York
- Northwell Health - New Hyde Park
Pennsylvania
- University of Pennsylvania - Philadelphia
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2021-03-26 |
| Est. Completion | 2029-12-30 |
| Phase | NA |
What the registry record for NCT03892980 still lists
NCT03892980 is an interventional study that assigns participants to a tested intervention. The registered 145 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Nipple Sparing Mastectomy appearing as the primary indexed condition, and to 1 intervention - of which Nipple-Sparing Mastectomy is the first listed.
NCT03892980 lists 6 locations in 6 states (Florida, Illinois, Minnesota).
Frequently Asked Questions
What is clinical trial NCT03892980 about?
NCT03892980 is a clinical study titled "Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy". This study evaluates the safety and effectiveness of the da Vinci Surgical Systems in prophylactic Nipple Sparing Mastectomy procedures.
What is the current status of trial NCT03892980?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 145 participants. The study started on 2021-03-26. Estimated completion is 2029-12-30.
What conditions does trial NCT03892980 study?
This clinical trial studies the following conditions: Nipple Sparing Mastectomy.
What interventions are being tested in trial NCT03892980?
The interventions under investigation include: Nipple-Sparing Mastectomy (DEVICE).
Who is sponsoring clinical trial NCT03892980?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03892980 being conducted?
This trial has 6 study locations across Florida, Illinois, Minnesota, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03892980's enrollment target sits among peer trials
145 705th of 2000 higher than 1,295 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02688959 · 145 participants · NA
Motor Attention Training for Attention Deficit Hyperactivity Disorder (ADHD)
- NCT03586609 · 145 participants · Phase 2
Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- NCT03767595 · 145 participants · NA
ProACT Post-Approval Study
- NCT03808337 · 145 participants · Phase 2
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI